Skip to main content
. Author manuscript; available in PMC: 2019 Jul 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2018 Oct 8;28(1):110–118. doi: 10.1158/1055-9965.EPI-18-0598

Table 2:

Relationship between inflammation proteins with lung cancer diagnosis among individuals with a negative LDCT screen

Univariable Multivariable

Control/Case Participants with a negative LDCT scan Participants with a negative LDCT scan

OR (95% C.I.) P OR (95% C.I.) P*

IL-6
    <25th Percentile 103/42 Reference Reference
    25th – 50th Percentile 103/58 1.38 (0.85–2.24) 0.19 1.48 (0.87–2.53) 0.15
    50th – 75th Percentile 103/73 1.74 (1.09–2.77) 0.02 1.88 (1.11–3.21) 0.02
    >75th Percentile 103/83 2.00 (1.26–3.16) 0.003 2.82 (1.64–4.86) <0.001
    Trend 1.40 (1.18–1.66) 0.002 1.40 (1.18–1.66) <0.001
    <Median 206/100 Reference Reference
    >Median 205/156 1.57 (1.14–2.15) 0.005 1.84 (1.26–2.68) 0.001

IL-8
    <25th Percentile 105/50 Reference Reference
    25th – 50th Percentile 104/69 1.40 (0.88–2.19) 0.15 1.57 (0.95–2.60) 0.08
    50th – 75th Percentile 105/52 1.04 (0.65–1.67) 0.87 1.08 (0.63–1.86) 0.77
    >75th Percentile 104/91 1.84 (1.18–2.85) 0.007 2.25 (1.37–3.71) 0.001
    Trend 1.18 (1.02–1.35) 0.02 1.25 (1.06–1.46) 0.006
    <Median 209/119 Reference Reference
    >Median 209/143 1.20 (0.88–1.63) 0.25 1.30 (0.90–1.86) 0.16

CRP
    <25th Percentile 105/50 Reference Reference
    25th – 50th Percentile 104/69 1.57 (0.98–2.52) 0.06 1.65 (0.96–2.83) 0.07
    50th – 75th Percentile 105/52 1.81 (1.14–2.87) 0.01 2.18 (1.28–3.71) 0.004
    >75th Percentile 104/91 1.76 (1.11–2.80) 0.02 2.46 (1.43–4.23) 0.001
    Trend 1.19 (1.03–1.37) 0.02 1.33 (1.13–1.58) 0.001
    <Median 209/119 Reference Reference
    >Median 209/143 1.39 (1.02–1.90) 0.04 1.73 (1.20–2.49) 0.003

IFN-g
    <25th Percentile 104/50 Reference Reference
    25th – 50th Percentile 103/57 1.15 (0.72–1.84) 0.56 1.11 (0.65–1.87) 0.72
    50th – 75th Percentile 104/64 1.28 (0.81–2.03) 0.29 1.28 (0.76–2.13) 0.35
    >75th Percentile 103/91 1.84 (1.18–2.85) 0.007 1.89 (1.16–3.09) 0.01
    Trend 1.22 (1.06–1.40) 0.005 1.24 (1.06–1.45) 0.007
    <Median 207/107 Reference Reference
    >Median 207/155 1.45 (1.06–1.98) 0.02 1.50 (1.06–2.14) 0.02

IL-12/IL-23p40
    <25th Percentile 105/50 Reference Reference
    25th – 50th Percentile 104/65 1.31 (0.83–2.07) 0.24 1.25 (0.73–2.12) 0.42
    50th – 75th Percentile 105/62 1.24 (0.78–1.97) 0.36 1.59 (0.93–2.72) 0.09
    >75th Percentile 104/85 1.72 (1.10–2.67) 0.02 2.49 (1.46–4.23) 0.001
    Trend 1.17 (1.02–1.35) 0.03 1.36 (1.15–1.61) 0.001
    <Median 209/115 Reference Reference
    >Median 209/147 1.27 (0.94–1.74) 0.12 1.77 (1.22–2.57) 0.002
*

P adjusted for age, gender, smoking status, pack-years of smoking, race, BMI, history of COPD, childhood asthma, adulthood asthma, asbestosis, chronic bronchitis, bronchiectasis, emphysema, fibrosis of the lung, pneumonia, sarcoidosis, silicosis, tuberculosis, diabetes, family history of lung cancer